Sunday February 23, 2020

Suicide is Preventable: Alarming Effects of Self-harm on Families, Communities, Societies

There are 3.5 male suicides for every female suicide, but three times as many females as males attempt suicide

4
//
Deliberate self harm
Feelings of helplessness, stemming from a variety of social and cultural factors can force an adolescent to indulge in self-harm. Pixabay
  • September 10 is observed as World Suicide Precention Day
  • Every year some 800,000 people die as a result of suicide
  • Suicide is the 3rd leading cause of death for 15 to 24-year-olds and 2nd for 24 to 35-year-olds
  • Suicide claims more lives than war, murder, and natural disasters combined
  • There are 3.5 male suicides for every female suicide, but three times as many females as males attempt suicide

Sept 11, 2016:

Dorothy Paugh was nine when her father took his life. “I count that day as the last day of my childhood. Because from that moment on, I had no sense of security. I had no sense that the world was a safe place,” she said.

Her father was buried at Arlington National Cemetery, a place of repose for presidents and military heroes. Paugh’s father served bravely in World War II. After his death, the White House sent a letter from “a grateful nation” that her mother hung prominently on the wall by the front door. Paugh says her mother wanted her children to remember their father as a war hero, and not to focus how he died. But, they never spoke about his death. Paugh said it was a special type of isolation.

Suicide is committed every year by the poor as well as the rich people.World Health Organization says about 75 percent of suicides happen in low and middle-income countries, where it was the second leading cause of death in 2012, the last year for which the WHO has statistics. In that year, it was the 15th leading cause of death worldwide. Young people between the ages of 15 and 29 are particularly vulnerable.

https://youtu.be/V4gLZj6gqjY

Follow NewsGram on Twitter

There are 3.5 male suicides for every female suicide, but three times as many females as males attempt suicide.

494,169 people visited a hospital for injuries due to self-harm behavior, suggesting that approximately 12 people harm themselves (not necessarily intending to take their lives) for every reported death by suicide.

Suicide is preventable

But medical experts say suicide is preventable, and they try to draw attention to that on World Suicide Prevention Day, which this year is September 10. Most suicidal individuals give warning signs or signals of their intentions. The best way to prevent suicide is to recognize these warning signs and know how to respond if you spot them.

Paul Gionfriddo, president of Mental Health America, compares suicide to the end stage of cancer, a terminal point in mental illness or disease.Gionfriddo said, “Suicide is the ultimate stage four event for a lot of people who have serious mental illnesses, and frankly it’s the ultimate stage four, late-stage event for a lot of people with other kinds of chronic diseases as well, too, who might not have had a mental illness.”

The best way to prevent suicide is through early detection, diagnosis, and treatment of depression and other mental health conditions.

On its web page, the World Health Organization notes that “early identification and treatment of depression and alcohol use disorders are key for the prevention of suicide…as well as follow-up contact with those who have attempted suicide, and psychosocial support in communities.” Experts also say people need to change the notion that those who commit suicide are cowards.Paugh says she thinks her father got overwhelmed. “He was no coward. He fought in World War II.”

Guns and suicide

The WHO urges countries to reduce access to the means of suicide. Statistics show having access to a firearm increases the risk of suicide, and in fact, in the U.S., half of all suicides are committed with a gun. Georges Benjamin, executive director of the American Public Health Association, said there are ways to change that statistic. “We can make the firearm safer. We can make people safer with their firearms, and then we can make the environment itself safer.”

Follow NewsGram on Facebook

Paugh’s son Peter bought a gun, to go target shooting and for protection. Then her life was shaken once more. “I lost my son in 2012,” she said. Peter was 25 years old when he shot himself.

Paugh often carries her favorite picture of her son. “It’s so understated, but he has piercing blue eyes. He’s paying attention. He’s looking at the world with love, I think.” And he has a hint of a smile on his handsome, young face.

One death every 40 seconds

Every year some 800,000 people die as a result of suicide. The World Health Organization says this translates to one death every 40 seconds. Beyond this, suicide impact families, societies, and communities.

Paugh agrees. “The ripple effect is enormous…his brothers, his girlfriend, myself, his father. It’s a shock that takes years to recover…to find footing again.”

The shock of the suicide deaths of her father and her son inspired her to become a suicide prevention advocate. “If we think someone may be troubled, ask them outright if they are having thoughts of suicide. It’s not a comfortable conversation, but it’s a lot more comfortable than a funeral….That’s my hope and my purpose in speaking about suicide. So people know it is preventable.” (VOA)

  • Karen Ercolani

    Suicide is not such a bad thing.

    :

  • Anubhuti Gupta

    ‘One death every 40 seconds’ Yet the help provided and the sensitisation is so less

  • Manthra koliyer

    People who attempt suicide are a threat to the society

  • Enakshi

    Suicide is no solution to ones problems, thank god its preventable now

Next Story

American Biotech Company Works with Chinese Officials to Test Drug Against Coronavirus

Trials to Test Ebola Drug's Potential to Prevent, Treat Coronavirus

0
Coronavirus
An American biotech company says it is working with Chinese authorities to determine the efficiency of a drug that can fight coronavirus. Pixabay

By Natalie Liu

An American biotech company says it is working with Chinese authorities to determine whether the antiviral drug remdesivir may provide an effective treatment for victims of the fast-spreading coronavirus known as COVID-19. The Chinese researchers hope to have the answer by May 1.

Officials of Gilead Sciences, which invented remdesivir as a treatment for Ebola and another disease, told VOA the company has initiated two clinical trials among infected patients “to determine the safety and efficacy of remdesivir as a potential treatment for the coronavirus.”

The trials have been warmly welcomed in China, where the nation’s official news agency celebrated the launch with a front page article. Anxious Chinese citizens have noted that the four syllables of remdesivir resemble the phrase as renmin-de-xi-wang, or people’s hope.

Coronavirus
A medical worker holds a thermometer to check a passenger’s temperature at a checkpoint as the country is hit by an outbreak of the coronavirus in Susong County, Anhui province, China. VOA

There are also more scientific reasons to be hopeful, including the case of an American coronavirus patient who experienced a speedy recovery in January, just 24 hours after being given remdesivir. Before the drug was administered, his symptoms had shown signs of worsening.

The first trial began enrolling patients on February 6, said a written statement from Gilead, which says it has provided China with “enough doses of remdesivir to treat up to 500 trial participants.” A Shanghai-based media outlet reported having seen a customs clearance form showing that 2,843 boxes of remdesivir arrived in Beijing on February 4.

The next day, a conference dedicated to the official launch of clinical trials took place at the Jinyintan Hospital in Wuhan, led by Dr. Bin Cao and his colleague Dr. Chen Wang, both top scientists practicing at the China-Japan Friendship Hospital in Beijing. Jinyintan Hospital has been treating some of the most critical COVID-19 cases since the outbreak began.

Gilead confirmed the trials are “being coordinated by the China-Japan Friendship Hospital in Beijing.” A filing registered with the U.S. National Library of Medicine lists the Beijing-based Capital Medical University as the trial’s main sponsor and Cao, a specialist in pulmonary critical care at the China-Japan Friendship Hospital, as the “responsible party.”

Research shows promise

In a scientific paper based on animal studies and published last week, scientists found remdesivir to be effective both for the prevention and treatment of the deadly Middle East Respiratory Syndrome coronavirus (MERS-CoV,) which is known to bear resemblances to COVID-19.

“Remdesivir prevented disease when administered before infection and improved the condition of macaques [monkeys] when given after the animals already were infected,” said scientists at the National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories in Hamilton, Montana.

Coronavirus
A medical worker calls his colleague inside an isolated ward at Jinyintan Hospital in Wuhan, the epicenter of the novel coronavirus outbreak, in Hubei province, China. VOA

Dr. Emmie de Wit, Chief of the Molecular Pathogenesis Unit in the Laboratory of Virology at the Montana facility, told VOA that she and her colleagues conducted their studies and submitted their results for review “well before the world knew of the outbreak in Wuhan.” De Wit said she and her colleagues learned about the coronavirus outbreak on Dec. 31.

Wuhan trials

In the Wuhan study, participants are divided into two groups — those “who have developed more severe clinical manifestations” such as requiring oxygen, and those who do not require oxygen.

“Patients will receive 10 days of intravenously administered remdesivir. The primary endpoint of both studies involves clinical improvement 28 days after treatment,” according to Gilead. Cao reported that 200 mg of remdesivir would be given to a group of patients on day one, followed by 100 mg once-daily “maintenance doses” for nine additional days.

Also Read- Russia Allows Chinese Nationals with Business Visas Despite Entry Ban

Patients in a control group were to be given placebos. To ensure objectivity, the identities of the patients receiving the placebos are masked from the participants, care providers, researchers and outcome assessors.

The researchers say they aim to complete the trials by April 3 and evaluate the results by May 1. (VOA)